HOWL — Werewolf Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Werewolf Therapeutics Reports Third Quarter 2021 Financial Results And Business Update
Werewolf Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Werewolf Therapeutics Reports Quarterly Loss Per Share Of $3.82
Brief: Werewolf Therapeutics Reports Second Quarter 2021 Financial Results And Business Update
Brief: Werewolf Therapeutics Announces Its Addition To The Russell 2000® Index
Brief: Werewolf Therapeutics Says Net Loss Was $7.4 Million For Q1 2021, Compared To $3.8 Million For Same Period In 2020
Brief: Werewolf Therapeutics Appoints Mike Sherman To Its Board Of Directors
U.S. STOCKS ON THE MOVE-Vimeo, Moderna, Pieris Pharmaceuticals, Novan, Virgin Galactic
U.S. STOCKS ON THE MOVE-Novan, Lordstown Motors, Shake Shack, United Airlines
Brokerages bet on Werewolf Therapeutics' PREDATOR cancer platform
U.S. RESEARCH ROUNDUP-Cimarex Energy, Dollar General, Werewolf Therapeutics
Werewolf Therapeutics: Jumps in Nasdaq debut
NASDAQ RESUMED AT 10:52 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 10:42 AM
Brief: Werewolf Therapeutics Shares Open 13.8% Above IPO Price In Nasdaq Debut
NASDAQ RESUMED AT 10:37 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
Brief: Werewolf Therapeutics Announces Pricing Of Upsized Initial Public Offering